95 related articles for article (PubMed ID: 2558622)
21. [Double blind randomized comparative study of two antihypertensive combinations. Enalapril-hydrochlorothiazide versus enalapril-nifedipine in 240 hypertensive patients resistant to monotherapy].
Frances Y; Lafay V; Madona O; Chastang C; Souchet T; Chazelle F
Therapie; 1996; 51(1):35-9. PubMed ID: 8762218
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
23. Enalapril, hydrochlorothiazide, and combination therapy in patients with moderate hypertension.
Frishman WH; Goldberger J; Sherman D
J Clin Hypertens; 1987 Dec; 3(4):520-7. PubMed ID: 2839628
[TBL] [Abstract][Full Text] [Related]
24. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
25. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Avanza AC; El Aouar LM; Mill JG
Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
27. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
Hermida RC; Ayala DE; Khder Y; Calvo C
Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
[TBL] [Abstract][Full Text] [Related]
28. [Combined drug therapy is better: successfully protecting elderly hypertensive patients].
Trenkwalder P
MMW Fortschr Med; 2008 Jul; 150(28-31):48-9. PubMed ID: 19009707
[No Abstract] [Full Text] [Related]
29. [Antihypertensive effectiveness of enalapril and hydrochlorothiazide as a combination drug].
Pirich C; Banyai M
Wien Med Wochenschr; 1993; 143(11):290-3. PubMed ID: 8212715
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of cicletanine efficiency and tolerance in hypertensive patients treated with beta-blockaders].
Clerson P; Deltour L; Billaut P; Tarrade T; Berthet P; Pauchant M
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1293-7. PubMed ID: 2573325
[TBL] [Abstract][Full Text] [Related]
31. [Combined treatment of arterial hypertension (results of the international program CLIP-ACCORD)].
Chazova IE; Ratova LG
Ter Arkh; 2009; 81(5):60-4. PubMed ID: 19537589
[TBL] [Abstract][Full Text] [Related]
32. Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension.
Levine JH; Ferdinand KC; Cargo P; Laine H; Lefkowitz M
Am J Hypertens; 1995 May; 8(5 Pt 1):494-9. PubMed ID: 7662226
[TBL] [Abstract][Full Text] [Related]
33. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
34. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
36. An appraisal of antihypertensive efficacy and adverse reactions with two drug regimens: enalapril maleate as part of triple therapy compared to conventional triple therapy in moderate to severe hypertension.
Fernandez PG; Kim BK; Galway AB
Pharmatherapeutica; 1984; 3(8):505-14. PubMed ID: 6322207
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
38. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
[TBL] [Abstract][Full Text] [Related]
39. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
40. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
